NSE Filings Explained

Fundraise

5Paisa Capital — Rights Issue Allotment NSE Signal

Successful completion of a ₹468.82 crore rights issue at a premium, indicating strong shareholder confidence and capital infusion for growth.

13-Apr-2026 22:14:11 ↑ 4-6%

Expansion

Acme Solar Holdings — Battery Storage Expansion NSE Signal

Commissioning of new 38 MW / 80.252 MWh battery storage capacity, expanding operational portfolio.

13-Apr-2026 21:40:06 ↑ 5-6%

Expansion

ACME Solar Holdings — Capacity Expansion NSE Signal

Subsidiary has fully commissioned its 100 MW wind power project, completing capacity expansion.

13-Apr-2026 21:11:02 ↑ 3-5%

Insider

Windsor Machines — Promoter Invests ₹40 Crore NSE Signal

Promoter group member invested ₹40 crore to convert warrants, increasing stake from 6.68% to 9.52%.

13-Apr-2026 20:00:31 ↑ 2-4%

M&A

Healthcare Global — Vizag Hospital Acquisition NSE Signal

Company completed acquisition of additional 34% stake in Vizag Hospital for ₹154.5 crore, increasing total holding to 85%.

13-Apr-2026 19:55:41 ↑ 3-5%

M&A

Pitti Engineering — NCLT Approves Amalgamation NSE Signal

NCLT approved amalgamation of two wholly-owned subsidiaries, simplifying corporate structure and creating operational synergies.

13-Apr-2026 19:44:15 ↑ 3-5%

Regulatory

Ujjivan Small Finance Bank — RBI Universal Bank Update NSE Signal

RBI acknowledges bank's diversification efforts but returns universal bank application, indicating regulatory engagement and clear path forward.

13-Apr-2026 18:57:21 ↑ 2-4%

Fundraise

Pakka Limited — ₹130 Cr Fundraise NSE Signal

Pakka Limited plans to raise ~₹130 Cr via preferential allotment of shares and warrants to fund its Jagriti Project expansion.

13-Apr-2026 18:53:02 ↑ 5-7%

Expansion

GAIL India — 600 MW Solar Expansion NSE Signal

Board approved major 600 MW solar power expansion with ₹3,295 crore investment.

13-Apr-2026 18:53:25 ↑ 5-6%

Earnings

Euro Panel Products — Strong FY26 Earnings NSE Signal

Company reported strong FY26 results with 19% revenue growth crossing ₹500 crore and 22.4% production volume increase.

13-Apr-2026 18:54:21 ↑ 3-5%

Regulatory

Indoco Remedies — US FDA Inspection NSE Signal

US FDA completed Pre-Approval Inspection with zero observations, clearing regulatory hurdle for facility.

13-Apr-2026 18:47:00 ↑ 3-5%

Fundraise

Mangalam Worldwide — Fundraise NSE Signal

Company to consider issuance of Secured Non-Convertible Debentures via private placement for fundraise.

13-Apr-2026 18:47:52 ↑ 3-5%